Basket | Login | Register

 
 
 
 

Clinical trials by country

Clinical Trials Watch

Austria

  1. CREAD
  2. ENGAGE

Belgium

  1. AMARANTH
  2. CREAD
  3. CREAD2
  4. DAYBREAK-ALZ
  5. EARLY
  6. EMERGE

Bulgaria

  1. COGNITE
  2. CREAD

Croatia

  1. CREAD

Czech Republic

  1. COGNITE
  2. CREAD
  3. DAYBREAK-ALZ
  4. MISSIONAD1 (planned)
  5. MISSIONAD2 (planned)

Denmark

  1. CREAD
  2. DAYBREAK-ALZ
  3. EARLY
  4. ENGAGE
  5. MISSIONAD2 (planned)

Estonia

  1. CREAD2

Finland

  1. CREAD
  2. EARLY
  3. EMERGE
  4. GENERATION
  5. MISSIONAD2 (planned)

France

  1. AMARANTH
  2. CREAD
  3. CREAD2
  4. DAYBREAK-ALZ
  5. EARLY
  6. EMERGE
  7. ENGAGE
  8. MISSIONAD1 (planned)
  9. MISSIONAD2 (planned)

Germany

  1. AMARANTH
  2. CREAD
  3. CREAD2
  4. DAYBREAK-ALZ
  5. EARLY
  6. EMERGE
  7. ENGAGE
  8. MISSIONAD1 (planned)
  9. MISSIONAD2 (planned)

Greece

  1. CREAD2
  2. MISSIONAD1 (planned)

Hungary

  1. AMARANTH
  2. COGNITE
  3. CREAD
  4. CREAD2

Italy

  1. AMARANTH
  2. CREAD
  3. CREAD2
  4. DAYBREAK-ALZ
  5. EMERGE
  6. ENGAGE
  7. MISSIONAD2 (planned)

Lithuania

  1. CREAD

Netherlands

  1. DAYBREAK-ALZ
  2. EARLY
  3. EMERGE
  4. GENERATION

Norway

  1. CREAD2

Poland

  1. AMARANTH
  2. COGNITE
  3. CREAD
  4. CREAD2
  5. DAYBREAK-ALZ
  6. EMERGE
  7. MISSIONAD1
  8. MISSIONAD2 (planned)

Portugal

  1. CREAD
  2. CREAD2
  3. DAYBREAK-ALZ
  4. ENGAGE
  5. MISSIONAD2 (planned)

Romania

  1. AMARANTH

Russia

  1. CREAD
  2. CREAD2
  3. DAYBREAK-ALZ

Serbia

  1. CREAD2

Slovakia

  1. MISSIONAD2 (planned)

Slovenia

  1. CREAD

Spain

  1. AMARANTH
  2. CREAD
  3. CREAD2
  4. DAYBREAK-ALZ
  5. EARLY
  6. EMERGE
  7. ENGAGE
  8. MISSIONAD1 (planned)
  9. MISSIONAD2

Sweden

  1. CREAD
  2. EARLY
  3. EMERGE
  4. MISSIONAD1 (planned)

Switzerland

  1. CREAD
  2. EARLY (planned)
  3. EMERGE
  4. GENERATION

Turkey

  1. CREAD
  2. CREAD2

Ukraine

  1. CREAD

UK

  1. AMARANTH
  2. CREAD
  3. CREAD2
  4. DAYBREAK-ALZ
  5. EARLY
  6. ENGAGE
  7. MISSIONAD1 (planned)
  8. SYMBAD

 

 
 

Last Updated: Thursday 10 August 2017

 

 
 

Options